Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Business Outlook For the second quarter of 2024, Tuniu expects to generate RMB114.9 million to RMB119.9 million of net revenue...
Tuniu sees significant revenue growth in Q4 2023, driven by packaged tours, and initiates a $10 million share repurchase program.
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...
Share Repurchase Program In March 2024, the Company's Board of Directors authorized a share repurchase program under which...
